SCHEMBL3225070

SCHEMBL3225070

O=C(O)[C@H](CO)N(Cc1ccccc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
LMNA P02545 2/20 0.47
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
NPSR1 Q6W5P4 2/20 0.40
HPGD P15428 1/20 0.40
ALPI P09923 1/20 0.40
PKM P14618 1/20 0.40
PTGS1 P23219 1/20 0.40
XIAP P98170 1/20 0.40
SLC7A5 Q01650 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8656510 0.86 KMT2A (0.47) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL8656502 0.86 KMT2A (0.47) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL10660607 0.86 MEN1 (0.49) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL9944007 0.86 KMT2A (0.47) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL1004997 0.85 ALDH1A1 (0.51) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL1004996 0.85 ALDH1A1 (0.51) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL295653 0.84 MDM2 (0.47) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL10420288 0.84 MEN1 (0.43) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL10420286 0.84 MEN1 (0.43) KMT2AMEN1LMNAALDH1A1POLB
SCHEMBL19100080 0.84 MEN1 (0.49) KMT2AMEN1LMNAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100092416-A1 METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS L'OREAL S.A. (FR) 2010-04-15 US disclosed
US-20100061953-A1 METHOD FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS AND COMPOSITION CONTAINING A GRAFTED AMINO ACID POLYMER L'OREAL S.A. (FR) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100061953-A1 METHOD FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS AND COMPOSITION CONTAINING A GRAFTED AMINO ACID POLYMER KRT18, CUTA, AADAT KMT2A 703/4885MEN1 1783/4885LMNA 1910/4885
US-20100092416-A1 METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS KRT18, CUTA, OAT KMT2A 588/4885MEN1 2847/4885LMNA 2465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.